Information
-
Trademark
-
88788756
-
International Classifications
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
- 42 - Scientific and technological services and research and design relating thereto
-
Filing Date
February 07, 2020
5 years ago
-
Transaction Date
January 26, 2024
a year ago
-
Status Date
December 14, 2023
a year ago
-
Location Date
December 14, 2023
a year ago
-
Status Code
602
-
Current Location
TMO LAW OFFICE 126- EXAMINING ATTORNEY ASSIGNED
Employee Name
DUENAS, TAYLOR S
-
Attorney Docket Number
AUGM-012020
Attorney Name
John M. Garvey
Law Office Assigned Location Code
N80
-
Owners
Mark Drawing Code
4000
Mark Identification
AUGMENTICON
Case File Statements
- GS0091: Virtual reality glasses; Virtual reality headsets; Downloadable augmented reality software for pharmaceutical research and manufacturing process evaluation and training; Downloadable virtual reality software for pharmaceutical research and manufacturing process evaluation and training; Downloadable virtual reality training simulation software in the field of pharmaceuticals; Recorded virtual reality software for pharmaceutical research and manufacturing process evaluation and training
- N00000: The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
- TR0010: The wording "AUGMENTICON" has no meaning in a foreign language.
- D10000: "AUGMENTICON"
- GS0421: Technology specification, namely, analyzing technology requirements and developing recommendations for the computer software and systems and other technology needed to meet those requirements, in the field of pharmaceuticals; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Testing, analysis, and evaluation of research and manufacturing processes to assure compliance with industry standards; Testing, analysis, and evaluation of research and manufacturing processes to assure compliance with pharmaceutical industry standards
Case File Event Statements
-
12/14/2023 - a year ago
24 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
12/14/2023 - a year ago
23 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
12/14/2023 - a year ago
22 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
12/4/2023 - a year ago
21 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/30/2023 - a year ago
20 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
8/30/2023 - a year ago
19 - FINAL REFUSAL E-MAILED
Type: GNFR
-
8/30/2023 - a year ago
18 - FINAL REFUSAL WRITTEN
Type: CNFR
-
7/11/2023 - a year ago
17 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Type: RCCK
-
12/20/2022 - 2 years ago
16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
5/13/2022 - 2 years ago
15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
9/20/2021 - 3 years ago
14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
2/22/2021 - 4 years ago
13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
2/22/2021 - 4 years ago
12 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
2/22/2021 - 4 years ago
11 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
2/1/2021 - 4 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
2/1/2021 - 4 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/1/2021 - 4 years ago
8 - ASSIGNED TO LIE
Type: ALIE
-
10/22/2020 - 4 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
5/6/2020 - 4 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
5/6/2020 - 4 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
5/6/2020 - 4 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/28/2020 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/12/2020 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
2/12/2020 - 5 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP